CHANGES IN GUT MICROBIOTA PROFILE IN PWHIV WHO SWITCH FROM EFV/FTC/TDF TO BIC/FTC/TAF
Background: Weight gain is often reported when virologically suppressed people living with HIV (PWHIV) switch to integrase inhibitors (INSTI). Reasons linking INSTI to weight gain are unclear and might be attributed to this HIV drug class, to coformulation with tenofovir alafenamide, and/or influenced by medications, lifestyle and environmental factors. One factor that could impact weight…